Outset Medical (Nasdaq: OM) shares got a boost today on fourth-quarter results that topped the consensus forecast on Wall ...

Q4 2024 Earnings Call Transcript February 19, 2025 Outset Medical, Inc. beats earnings expectations. Reported EPS is $-0.37, ...

Outset Medical is prominently recognized for its innovative Tablo Hemodialysis System, which revolutionized the dialysis ...

Outset provided 2025 revenue guidance of $115 million to $125 million, and non-GAAP gross margin guidance in the high-30% range. Additionally, the company expects to use less than $50 million of cash ...

Outset provided 2025 revenue guidance of $115M to $125M , and non-GAAP gross margin guidance in the high-30% range. Additionally, the company ...

Outset Medical Inc (OM) reports sequential revenue growth, improved gross margins, and a strengthened balance sheet, despite challenges in console sales and manufacturing overhead.

Outset Medical (Nasdaq: OM) announced today that the FDA says it addressed all issues cited in a 2023 warning letter.

Outset Medical, Inc., a medical technology company focused on innovative dialysis solutions, announced that the FDA has confirmed the resolution of all issues raised in a Warning Letter the ...

Outset Medical, Inc. (OM) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...

Welcome to the Outset Medical fourth-quarter 2024 earnings conference call. (Operator Instructions) Please be advised today's conference is being recorded. I would now like to hand the conference over ...

SAN JOSE, Calif., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and ...